Harbor Healthcare Consultants, a leading mergers and acquisitions advisory firm specializing in pharmacy transactions, is pleased to announce the successful sale of one of IV Services to Genefic, a premier provider of comprehensive infusion and specialty pharmacy services.
The transaction represents a strategic move for both parties. IV Services, a respected provider of infusion therapies, has found an ideal partner in Genefic, a company known for its commitment to expanding access and enhancing patient care. This acquisition will allow Genefic to strengthen its presence in the Louisiana region, offering a wider range of services to the local and surrounding communities.
“We are thrilled to have found the right partner in Genefic,” said Trey Biggs, CEO of IV Services. “Harbor Healthcare Consultants played an instrumental role in this process, guiding us every step of the way and ensuring that we achieved the best possible outcome for our business and our patients.”
Genefic’s CEO, Dan Riley, added, “This acquisition aligns perfectly with our mission to expand access to high-quality infusion and specialty pharmacy services. We look forward to integrating IV Services operations and continuing to deliver exceptional care to patients in the serviceable area.”
Mark Alford, Managing Director at Harbor Healthcare Consultants, commented on the transaction, stating, “Our goal is to unlock maximum value for our clients. In this case, we were able to connect IV Services with a buyer that not only achieved their financial objectives but also shared their commitment to patient care. We are proud to have facilitated this successful partnership.”
The sale underscores Harbor Healthcare Consultants’ expertise in navigating complex healthcare transactions and their dedication to achieving favorable outcomes for their clients.
About IV Services
IV Services is a leading provider of infusion therapies, committed to delivering high-quality care and improving patient outcomes. With a strong presence in the New Orleans area, IV Services offers a wide range of infusion pharmacy services designed to meet the needs of patients with complex medical conditions.
About Genefic
A wholly-owned subsidiary of Dalrada Financial Corporation, Genefic proudly delivers frontline health products and services through redesigned systems and reimagined patient care. Genefic’s unique pharmacy solution, Genefic Specialty Pharmacy, offers more than 30 years of dedicated expertise providing patient advocacy through end-to-end prescription services, medical education, and patient advocacy and support.
About Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm founded in 1995 by its President and pharmacist, Ira Cammeyer. Harbor offers a variety of M&A advisory services to middle market healthcare and pharmacy businesses. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, infusion, compounding and 340B pharmacies. Harbor offers regulatory and advisory expertise while maintaining business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions